Cargando…
Correction: Sangadala, S. et al. FK506 Induces Ligand-Independent Activation of the Bone Morphogenetic Protein Pathway and Osteogenesis. Int. J. Mol. Sci. 2019, 20, 1900
Autores principales: | Sangadala, Sreedhara, Devereaux, Emily J., Presciutti, Steven M., Boden, Scott D., Willett, Nick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503922/ https://www.ncbi.nlm.nih.gov/pubmed/32878009 http://dx.doi.org/10.3390/ijms21176287 |
Ejemplares similares
-
FK506 Induces Ligand-Independent Activation of the Bone Morphogenetic Protein Pathway and Osteogenesis
por: Sangadala, Sreedhara, et al.
Publicado: (2019) -
Sclerostin small-molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways
por: Sangadala, Sreedhara, et al.
Publicado: (2023) -
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020) -
Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011) -
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992)